SmPC- Amiloride 5mg Tablets BP: Change history
View Summary of Product Characteristics (SmPC- Amiloride 5mg Tablets BP)
Last updated on this site: 26 Nov 2024
II, C.I.2.b: To update sections 4.4, 4.5, 4.8, 5.1 and 5.2 of the SmPC to bring in line with the reference product Amiloride HCl/Hydrochlorothiazide Teva 2.5/25 mg, 5/50mg comprimés. Consequentially, the PIL is being updated.
View Summary of Product Characteristics (SmPC- Amiloride 5mg Tablets BP)
Last updated on this site: 26 Nov 2024
II, C.I.2.b: To update sections 4.4, 4.5, 4.8, 5.1 and 5.2 of the SmPC to bring in line with the reference product Amiloride HCl/Hydrochlorothiazide Teva 2.5/25 mg, 5/50mg comprimés. Consequentially, the PIL is being updated.
-
Changes: (Updated: 26 Nov 2024)
II, C.I.2.b: To update sections 4.4, 4.5, 4.8, 5.1 and 5.2 of the SmPC to bring in line with the reference product Amiloride HCl/Hydrochlorothiazide Teva 2.5/25 mg, 5/50mg comprimés. Consequentially, the PIL is being updated.
-
Changes: (Updated: 28 Mar 2023)
Description of update: To update the ATC code for `Amiloride' as published by WHO - Aldosterone antagonists. Consequently, section 5.1 of the SmPC has been updated.
Sections of SmPC updated: 5.1, 10.
-
Changes: (Updated: 20 Sep 2022)
initial upload